TB-500.
A regenerative peptide for slow-healing tissues — tendons, ligaments, and fascia.
Pricing is shown after your free assessment, before you commit.
Free to start. No card required.
Reviewed by Lumora clinical team (Licensed provider network)Mixed evidenceSource: Client-approved product catalog; provider review required
Evidence, regulatory status, and fit vary by medication, formulation, route, and individual history.
Is this for you?
This is for you if
- Patients with long-standing or stubborn injuries
- Patients with chronic stiffness or limited mobility
- Active patients with repeat-strain injuries
- Patients recovering from surgery or intense training
- Patients needing support beyond BPC-157 alone
This isn't for you if
Generally well tolerated. Not FDA-approved. Not appropriate during pregnancy or with active malignancy.
TB-500
TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring repair peptide. It is used in physician-supervised protocols for tissues that traditionally heal slowly.
Mechanism and fit.
TB-500 promotes new blood vessel formation, supports cell migration, and stimulates actin — a key structural protein involved in muscle and connective tissue repair. This makes it particularly useful for tendons, ligaments, fascia, and post-surgical or chronic-overuse recovery.
Who this is typically for.
- Patients with long-standing or stubborn injuries
- Patients with chronic stiffness or limited mobility
- Active patients with repeat-strain injuries
- Patients recovering from surgery or intense training
- Patients needing support beyond BPC-157 alone
What patients
most often ask.
Can I use TB-500 with BPC-157?
Yes — they are often paired (the 'Wolverine Stack') because they support different parts of the repair process. BPC-157 calms inflammation and supports baseline healing; TB-500 promotes circulation and cell migration.
Is TB-500 safe for athletes?
TB-500 is on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes should consult their governing body before use.
Who this is typically for.
These are common fit patterns from the approved catalog. Your provider determines whether treatment is appropriate.
- <ul><li>Patients with long-standing or stubborn injuries</li><li>Patients with chronic stiffness or limited mobility</li><li>Active patients with repeat-strain injuries</li><li>Patients recovering from surgery or intense training</li><li>Patients needing support beyond BPC-157 alone</li></ul>
How this option
is evaluated.
The plan is provider-determined after reviewing your assessment and safety factors.
- DosingOnce daily in the morning, typically 5 days on / 2 days off, by subcutaneous injection.
- Typical duration6–8 weeks per cycle.
- Safety and eligibilityYour provider reviews contraindications, medication interactions, goals, and safety factors before prescribing.
- A licensed provider reviews your assessment before any treatment is recommended.
- You see full pricing - visit fees, medication, labs, follow-up - before you commit.
- Your plan can be adjusted, paused, or stopped based on response and safety. Your clinician is reachable - not a chatbot.
- Compounded medications are not FDA-approved and are dispensed only when prescribed by a licensed provider.
Start with
provider review.
If you are considering TB-500, the first step is a free assessment. A provider determines whether it fits your goals and medical history.
A provider determines whether treatment is clinically appropriate.